Trials / Unknown
UnknownNCT03218059
Outcome After MTX & Transvaginal Surgery or UAE & Uterine Curettage in Patients With Cesarean Scar Pregnancy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Shanghai First Maternity and Infant Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Cesarean scar pregnancy (CSP)is one of the more serious complications of pregnancies that occur after a prior cesarean delivery. No clinical guidelines have been issued for the management of CSP. More than 30 treatment methods are reported to be used in managing CSP. However, which management can achieve better clinical effects remains unknown. Therefore, this prospective study is designed to compare the outcome between MTX + transvaginal surgery and UAE + D\&C in the treatment of CSP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Methotrexate Combined With Transvaginal Surgery | The methods of treatment of CSP |
Timeline
- Start date
- 2017-07-15
- Primary completion
- 2018-06-01
- Completion
- 2018-12-01
- First posted
- 2017-07-14
- Last updated
- 2017-07-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03218059. Inclusion in this directory is not an endorsement.